The effects of stem cell factor (SCF) have been tested on a murine bone marrow subpopulation (RH123'O. Lin-, LyGA/ E+) that is highly enriched for long-term hematopoietic repopulating cells. SCF maintained cells from this population with long-term repopulating ability for up to 10 days in vitro. However, compared with freshly isolated cells, the level of engraftment in vivo by the cultured cells declined during the in vitro culture period, suggesting that SCF alone was unable to stimulate the self-renewal of long-term repopulating cells.
By direct visualization of cultures, only small numbers of cells survived and rarely underwent cell division. However, SCF did directly stimulate proliferation of a population (Rh123".d'h', Lin-, LyGA/E+) enriched for short-term repopulating cells. These data suggest that stem cell dfierentiation is associated with the development of mitogenic activity by SCF at least in some progenitor cell populations. 0 1994 by The American Society of Hematology.
growthlsurvival factor. However, this ability to promote survival of the long-term repopulating cells in vitro is limited and transient.
MATERIALS AND METHODS

Animals.
Mice were used at 6 to 12 weeks of age and were of the following strains: C57BWKa-Thy-1.1 (Thy-l .l, Ly5.2) and C57BL/6-Ly-5.1-Pep3b(Thy-1.2,Ly5.1). They were bred at The Walter and Eliza Hall Institute of Medical Research animal facility under specific pathogen-free conditions and were maintained on acidified water.
Fluorescence-activated cell sorting (FACS).
To prepare cells for FACS, 10 C57BWKa-Thy-1.1, Ly5.2 mice were killed by cervical dislocation, and cells from both femurs and tibiae were flushed out using a 2.5-mL syringe with a 21-gauge needle. After washing, the bone marrow cells were resuspended in 10 mL balanced salt solution containing 5% fetal calf serum (BSS.FCS) and 0.1 pg/mL rhodamine123 (Eastman Kodak CO, Rochester, NY) and incubated at 37°C for 30 minutes. After washing once, the cells were resuspended in 10 mL fresh BSS.FCS and incubated at 37°C for another 30 minutes. The cell suspension was then diluted further by the addition of 10 mL of BSS.FCS, layered on top of Ficoll (Pharmacia Inc, Piscataway, NJ), and centrifuged at 1,600g for 10 minutes at room temperature. Light-density, viable bone marrow cells were recovered and washed with 10 mL of BSS.FCS. After washing and resuspension in 3 mL of BSS.FCS, the cells were incubated on ice for 15 minutes with a mixture of rat monoclonal antibodies (MoAbs), GK1.5, 53-6.72, 53-7.3.13, RA3-6B2, Ml/70.15.11.5, and RB6-8C5, reactive with specific antigens on mature T, B, and myeloid cells (neutrophils and monocytedmacrophages). After washing with 10 mL BSS.FCS and centrifugation through an FCS underlayer, the cells were resuspended in 1 mL of BSS.FCS, mixed together with 1 mL of prewashed magnetic Dynalbeads (Dynalbeads M450; Dynal Inc, Oslo, Norway), and incubated for 20 minutes at 4°C with constant mixing. After diluting the mixture by adding 5 mL of fresh BSS.FCS, the beads, together with the cells bound to them, were removed magnetically. This procedure was repeated twice to both bead and bead-free cell populations. The bead-free cell fractions (lineage antigen depleted, Lin-) were pooled, centrifuged, and then stained sequentially at 4°C for 15 minutes each in 0.5 mL of phycoerythrin (PE)-conjugated goat antirat Ig (mouse absorbed), biotinylated E13-161.7 MoAb (anti-Ly6NE). and Texas red-avidin. Each staining step was followed by a washing step with 10 mL of BSS.FCS. The bone marrow cells were preincubated with 50 pg normal rat Ig for 2 to 3 minutes before the addition of biotinylated E l 3-161.7 MoAb. After the final wash, the cells were resuspended in 3 mL of BSS.FCS containing 10 pg/mL propidium iodide (Calbiochem Corp, La Jolla, CA), and filtered through a 63-pm pore size nylon screen. FACS was performed using an unmodified FACStar-Plus instrument (Becton Dickinson Immunocytometry Systems, San Jose, CA). Cells were positively sorted into Rh123'", Lin-, Ly6A/E+ and Rh123med"', Lin-, For personal use only. on October 30, 2017. by guest www.bloodjournal.org From Ly6AIE populations as described previously.'8 All cells were kept at 4°C throughout the whole procedure. After completion of cell sorting, the deflected cells were centrifuged at 1,500 rpm for 5 minutes, resuspended, and counted using a hemocytometer.
In vitro cultures. For semisolid l-mL agar cultures, unfractio~ted marrow cells were cultured at 5 X 104 cells per culture and marrow Lin-, Ly6AiE+ cells fractionated into Rh123'O or Rh123medmi subpopulations were cultured at 150 to 250 cells per culture in triplicate 35-mm petri dishes. The cells were stimulated by individual or indicated combinations of the following growth factors at 1, OOO U/mL, unless otherwise specified: murine L-3, GM-CSF, M-CSF, leukemia inhibitory factor (LIF), or human G-CSF (prepared and kindly provided by Dr N.A. Nicola, Hall Institute, Melbourne, Australia). Human L -6 (kindly provided by Sandoz, Basel, Switzerland) and rat SCF (kmdly provided by Dr K.M. Zsebo, Amgen, Thousand Oaks, CA) were used at 0.5 pg/mL and 100 ng/mL, respectively. Recombinant human L-l (kindly provided by Dr A. Gearing, British Biotechnology, Oxford, UK) was used at 100 U/mL. Recombinant murine tumor necrosis factor ( I (TNFa; kindly provided by Genetech, San Francisco, CA) was used at 10 ng/mL. Colonies of more than 50 cells were scored at day 12 of incubation. mL. Cells were incubated at 37°C in 10% CO2 in air in a fully humidified atmosphere. For proliferation assays, the cells were pulsed with 1 pCi/mL of 13H]TdR and incubated for an additional 16 hours. Samples were then harvested onto glass fibre filters, dried, and counted using the Inotech Trace-96 gas ionization counting system (Biosystem Intl, Inc, Lansing, MI).
Transplantation. Recipient animals (C57BL/6-Ly-5.1-Pepsb) were exposed to 11.0 Gy of y radiation from a I3' Cs source (Atomic Energy, Ottawa, Canada) at a dose rate of 3 1 cGy/min. The 11 .OGy dose was delivered in two equal exposures, administered 3 hours apart. Irradiated recipients were transplanted intravenously with indicated numbers of Rh123'", Lin-, Ly6A/E' cells before and after stimulation with the indicated growth factor(s), together with 5 X 1 6 compromised bone marrow ~e1ls.l~ Animals were maintained on aqueous antibiotic (neomycin sulphate, 1.1 g/L) for at least 3 weeks after transplantation. Hematopoietic reconstitution was determined by the percentage of donor-derived (Ly5.2+) nucleated cells in the peripheral blood of recipient animals (Ly5.1) using Ly5.2 allelicspecific MoAb, S450-15.2 (kindly provided by Dr I. Mackenzie, University of Melbourne, Victoria, Australia), together with rat MoAbs, RA3-6B2 (for B cells) and Gk1.5 and 53-6.72 (for T lymphocytes). Forward and perpendicular light scatter together with absence of staining with 6B2, GK1.5, and 53/6.7 MoAbs were used to define granulocytes and monocytes/macrophages, and the presence of cells from these lineages was confirmed by using the myelomonocytic-specific rat MoAbs, RB6-8C5 and MWO. Table 1 , SCF stimulated in vitro colony formation by normal bone marrow cells. When FACS-sorted Rh123'", Lin-, Ly6A/E+ (Rh123") and Rh123""&', Lin-, Ly6A/E+ (Rh123"'") cells were used as target cells, colony formation stimulated by SCF was only observed in cultures of R123"'&' cells, with a frequency of 1 to 2 colonies per 1 0 0 cells. When combined with IL-3, IL-6, or G-CSF, SCF synergistically stimulated significant numbers of colonies from both populations ( Table 1) . These colonies were macro- scopic in size and were readily apparent to the naked eye. SCF did not synergize with GM-CSF, M-CSF, L-l, IL-4, IL-5, T N F , and LIF, nor did these factors alone stimulate colony formation when the Rh123'', Lin-, Ly6AIE+ cells were used (data not shown). Because SCF alone was unable to stimulate colony formation by Rh1231°, Lin-, Ly6A/E' cells, we investigated whether it could enhance their survival in vitro. To test this possibility, delayed-addition experiments were performed. Semisolid agar cultures of Rh1231°, Lin-, Ly6A/E+ cells were established, with and without SCF. After varying periods of incubation, a combination of cytokines (IL-l, L-3, IL-6, SCF, GM-CSF, G-CSF, and M-CSF) that have previously been shown to stimulate maximal colony formation by Rh1231°, Lin-, Ly6A/E+ cells'* were then added to the cultures. The cultures were then examined after a further 12 days of incubation. As shown in Fig lA, in the presence of medium alone, the colony-forming ability of the Rh123", Lin-, Ly6A/E+ cells disappeared within 3 to 4 days, and by day 5 no cells capable of responding to the addition of multiple growth factors were present. However, significant numbers of colony-forming cells were maintained, for at least 7 days, when SCF was initially present in the cultures (Fig IA) . Additional experiments were performed (data not shown), in which the initial culture period was extended to 14 days. No cells capable of forming colonies were detected after 10 to 12 days of incubation. This was not caused by the depletion of SCF, because the addition of a fresh aliquot of SCF on day 7 of the initial culture period did not result in prolonged colony-forming ability of the Rh123'" cells. A similar concentration of SCF was required for the synergistic and survival-enhancing activities on Rh123Io, Lin-, Ly6A/E+ cells (Fig 2) . Similar experiments, involving delayed addition of multiple growth factors, were performed in liquid cultures with uptake of H'TdR being used to monitor cellular proliferation 7 days after the addition of the cocktail of growth factors. It was observed that the H3TdR uptake in cultures initially containing SCF was significantly higher than in cultures containing only medium (Fig lB) , but remained relatively constant for the first 3 days of culture before starting to increase at day 4 (Fig 1B) . This suggests that the total number of multiple-factor-responsive cells increases after a latent period of 3 to 4 days. This conclusion was confirmed by daily microscopic observation of the cultures. Virtually no identifiable live cells could be seen after 7 days of incubation in medium alone. However, small, irregular, highly refractile cells, mostly single and occasionally as doublets, were seen in cultures containing SCF (Fig 3) . Cell doublets were seen only from day 4 onward and they rarely increased to 3 or 4 cells. Consistent with the semisolid agar culture results, viable cells disappeared from cultures by day 10 to 12.
RESULTS
As shown in
To determine the in vivo developmental potential of the Rh123'', Lin-, Ly6A/E+ cells maintained in vitro by SCF, liquid suspension cultures each of 1, OOO Rh123'' cells from Ly-5.2 mice were established. Control cultures consisted of cells in culture medium alone. Immediately after the establishment of the cultures, cells were harvested and divided by culture volume such that individual lethally irradiated Ly-5.1 recipients each received 100,25, or 10 Rh123'' cells (ie, '/lo, 'h, and l/,,,,, of the culture volume, respectively). After 1, 4, 7, 10, and 14 days of incubation, cells were harvested and divided equally by culture volume, such that individual lethally irradiated Ly-5.1 recipients each received '/lo of the contents of each culture. To prevent premature death caused by lack of short-term hematopoietic repopulation, each recipient animal also received 5 X lo5 Ly-5.1 "compromised" bone marrow cells." The numbers of nucleated donor cells repopulating the peripheral blood of recipients was determined by flow cytometry, using an Ly-5.2 allelic-specific MoAb as described in the Materials and Methods. We have previously shown that the proportion of donor cells in the peripheral blood accurately reflects the donor contribution to other hematopoietic tissues.*' Transplanted recipients were examined at 4 to 5 weeks (Fig 4A) and at 5 months ( Fig   4B) after transplantation. These time points were chosen to cover engraftment by putative short-and/or long-term in vivo repopulating cells. Transplantation of 10, 25, or 100 Rh123'" cells, without incubation, resulted in a mean of 6% t 9%, 21% ? 19%, and 48% t 21% and 7% t 12%, 25% 2 25%, and 49% ? 20% donor cells in the peripheral blood 4 weeks and 5 months posttransplantation, respectively.
There was no significant difference in the level of donor cell engraftment after 1 day of incubation by cells from SCFcontaining or medium alone control groups (17% rt 11% v 20% ? 16% at 4 weeks and 45% ? 39% v 35% 5 36% at 5 months). The mean level of donor cell engraftment, conferred by the cells cultured for 1 day, was generally lower than the starting cell population. This difference between starting cells and l-day cultured cells was only statistically significant in animals 4 weeks after transplantation (48% 2 21% v 17% t 11% [SCF group], P < .05; and 48% t 21% v 20% ? 16% [medium group], P < .05), but not at 5 months For personal use only. on October 30, 2017. by guest www.bloodjournal.org From after transplantation (Fig 4) . This result suggests that some stedprogenitor cells responsible for the early phase of in vivo hematopoietic repopulation died within the first 24 hours of culture, regardless of whether SCF was present. By day 4 of incubation, all of these putative early repopulating cells had died in the control cultures, as evident by the absence of detectable donor-derived cells in the recipients monitored at 4 weeks posttransplantation. However, a few longterm repopulating cells survived in these conditions, as evidenced by the appearance of donor cells in 3 of 9 recipients at 5 months posttransplantation. The kinetics of this delayed-onset type of engraftment seen with cells taken from control medium cultures is shown in Fig 5. By day 7 of incubation of control cultures, all of the short-and longterm in vivo hematopoietic repopulating ability had been lost. By contrast, the majority of mice transplanted with cells incubated for up to 7 days with SCF displayed varying levels of donor cell engraftment at 4 weeks and 5 months posttransplantation. These data indicate that cells with short-andor long-term in vivo hematopoietic repopulating ability were present in cultures stimulated with SCF. However, there was a steady decline in the repopulating ability of these cells after 7 days of incubation and no donor cells were detected from cells cultured for 14 days in SCF (Fig 4) .
At both 4 weeks and 5 months posttransplantation, the proportion of donor cells in each of the T-cell, B-cell, and myeloid (neutrophil and monocyte) compartments in the peripheral blood was determined. In most cases in which donor cells comprised greater than 20% of the total peripheral blood nucleated cell population, these cells could be detected in both lymphoid and myeloid lineages. The results, at 5 months, for animals transplanted with 100 control cells, cells incubated with SCF for 7 days, or cells incubated in medium alone for 4 days are shown in levels of engraftment with cells incubated in SCF, there is no significant difference between control cells and cells incubated for 7 days in SCF (Fig 6A and B) . This indicates that SCF is able to maintain pluripotential stem cells in vitro. Interestingly, animals transplanted with cells from 4-day medium alone cultures had consistently high levels of B-cell and myeloid cell repopulation, but only low levels of T-cell repopulation.
Unlike SCF, a variety of cytokines, including L-l, IL-3, when used alone, were unable to maintain the short-or longterm repopulating ability of Rh123", Lin-, Ly6A/E+ cells after 7 days of in vitro culture (data not shown).
IL-4, IL-5, IL-6, IL-7, G-CSF, GM-CSF, M-CSF, and LIF,
DISCUSSION
These studies have examined the effects of the ligand for c-kit (SCF) on a highly enriched population of murine bone marrow cells (lU1123", Lin-, Ly6A/E+) possessing longterm hematopoietic repopulating potential. The result of direct visualization showed that SCF alone was only weakly mitogenic for a small population (1 % to 5%) of these cells, at best stimulating 2 cell divisions. However, SCF alone was able to maintain the long-term repopulating ability of this cell population. could support the survival of multipotential progenitors present in the Lin-triply 5-fluorouracil-treated marrow population. However, the ability of these surviving cells to engraft recipients long term was not tested. LIF and IL-3 have been implicated as being able to enhance the survival in vitro of murine hematopoietic repopulating ~e l l s .~~*~' Such effects were not observed in our studies using purified Rh123", Lin-, Ly6A/E+ cells. This suggests that the presence of virus-producing fibroblasts and the use of unfractionated bone marrow cells as target cells in these former experiments results in the survival-enhancing effect of these cytokines being indirect and possibly mediated by accessory cells present in the culture. The present studies showed that, in the absence of accessory cells, SCF is the only soluble cytokine tested so far that is able to maintain long-and short-term in vivo repopulating cells for up to 10 days in vitro. However, cocultivation studies using the stromal cell line S 17 indicated the existence of a yet unidentified stromal cell-derived factor(s) other than SCF for the maintenance of long-term repopulating cells in vitro. 26 The in vivo reconstitution behavior of the Rh123'", Lin-, Ly6A/E+ cells that survived in culture medium for 4 days without the presence of exogenously added growth factors suggests that these cells may represent the "putative" primitive hematopoietic pluripotential stem cells without any capacity for early phase engraftment (see the delayed onset of engraftment shown in Fig 5) . This observation also indicates that Rh123'". Lin-, Ly6A/E+ cells are still a heterogenous population composed of both short-and long-term in vivo hematopoietic repopulating cells. By placing the Rh123'O, Lin-, Ly6A/E+ cells into culture medium for 2 to 4 days may be a simple means of further enriching of the most primitive hematopoietic pluripotential stem cells from the day-l2 CFU-S and short-term hematopoietic repopulating cells. The reconstitution behavior of these putative primitive stem cells in different cell (B, T, and myeloid) lineages was quite distinctive from that of freshly isolated Rh123'', Lin-, Ly6A/E+ cells. Although high levels of engraftment were seen in both B-cell and myeloid cell lineages, there was only 10% to 15% donor cell engraftment in the T-cell lineage. Whether this is an inherent property of Rh123'", Lin-, Ly6N E' cells that survive in culture in the absence of growth factors remains to be determined. Alternatively, it is possible that the thymus of the irradiated hosts is either not functioning normally or is not receptive by the time the prothymocytes are generated.
There have been many report^^.^"^ demonstrating that SCF alone can stimulate colony formation by unfractionated bone marrow cells and fractionated populations enriched for progenitor cells. Similar results were obtained in the present experiments. Taken together with the effects on long-term repopulating cells, the data suggest that differentiation of stem cells into some hematopoietic lineages is associated with an increased mitogenic response to SCF.
It remains to be determined whether any combinations of known hematopoietic growth factors can increase the absolute numbers of long-term repopulating cells in vitro. The present results indicate that SCF alone is unable to perform this function.
